Anika Therapeutics
ANIK
$26.94
Share price
1.72%
Change (1 day)
3.63%
Change (1 year)
Categories
P/S ratio for Anika Therapeutics (ANIK)
P/S ratio as of May 2024 (TTM): 2.36
According to Anika Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.35691. At the end of 2023 the company had a P/S ratio of 1.99.
P/S ratio history for Anika Therapeutics from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 1.99 | -28.08% |
| 2022 | 2.77 | -20.94% |
| 2021 | 3.50 | -29.58% |
| 2020 | 4.97 | -23.2% |
| 2019 | 6.47 | 43.06% |
| 2018 | 4.52 | -35.07% |
| 2017 | 6.97 | 0.63% |
| 2016 | 6.93 | 12.24% |
| 2015 | 6.17 | 7.68% |
| 2014 | 5.73 | -21.1% |
| 2013 | 7.26 | 276.01% |
| 2012 | 1.93 | -6.29% |
| 2011 | 2.06 | 27.34% |
| 2010 | 1.62 | -36.55% |
| 2009 | 2.55 | 163.78% |
| 2008 | 0.9671 | -81.74% |
| 2007 | 5.30 | -0.55% |
| 2006 | 5.33 | 29.45% |
| 2005 | 4.11 | 15.77% |
| 2004 | 3.55 | -43.72% |
| 2003 | 6.31 | 725.65% |
| 2002 | 0.7648 | -13.42% |
| 2001 | 0.8833 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 3.92 | 66.17% | 🇺🇸 USA |
 Medtronic MDT | 3.32 | 41.00% | 🇮🇪 Ireland |
 Stryker Corporation SYK | 6.09 | 158.40% | 🇺🇸 USA |
 STAAR Surgical STAA | 6.81 | 188.94% | 🇺🇸 USA |
 Halozyme Therapeutics HALO | 6.02 | 155.48% | 🇺🇸 USA |
 Hill-Rom HRC | N/A | N/A | 🇺🇸 USA |